Sökning: onr:"swepub:oai:lup.lub.lu.se:00d5ad67-e55a-47ba-8a31-750866e6989b" > Use of the BOADICEA...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04538naa a2200529 4500 | |
001 | oai:lup.lub.lu.se:00d5ad67-e55a-47ba-8a31-750866e6989b | |
003 | SwePub | |
008 | 170811s2018 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/00d5ad67-e55a-47ba-8a31-750866e6989b2 URI |
024 | 7 | a https://doi.org/10.1007/s10689-017-0014-x2 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Brédart, Anneu Curie Institute, Paris,Paris Descartes University4 aut |
245 | 1 0 | a Use of the BOADICEA Web Application in clinical practice : appraisals by clinicians from various countries |
264 | c 2017-06-16 | |
264 | 1 | b Springer Science and Business Media LLC,c 2018 |
520 | a The ‘BOADICEA’ Web Application (BWA) used to assess breast cancer risk, is currently being further developed, to integrate additional genetic and non-genetic factors. We surveyed clinicians’ perceived acceptability of the existing BWA v3. An online survey was conducted through the BOADICEA website, and the British, Dutch, French and Swedish genetics societies. Cross-sectional data from 443 participants who provided at least 50% responses were analysed. Respondents varied in age and, clinical seniority, but mainly comprised women (77%) and genetics professionals (82%). Some expressed negative opinions about the scientific validity of BOADICEA (9%) and BWA v3 risk presentations (7–9%). Data entry time (62%), clinical utility (22%) and ease of communicating BWA v3 risks (13–17%) received additional negative appraisals. In multivariate analyses, controlling for gender and country, data entry time was perceived as longer by genetic counsellors than clinical geneticists (p < 0.05). Respondents who (1) considered hormonal BC risk factors as more important (p < 0.01), and (2) communicated numerical risk estimates more frequently (p < 0.001), judged BWA v3 of lower clinical utility. Respondents who carried out less frequent clinical activity (p < 0.01) and respondents with ‘11 to 15 years’ seniority (p < 0.01) had less favourable opinions of BWA v3 risk presentations. Seniority of ‘6 to 10 years’ (p < 0.05) and more frequent numerical risk communication (p < 0.05) were associated with higher fear of communicating the BWA v3 risks to patients. The level of genetics training did not affect opinions. Further development of BWA should consider technological, genetics service delivery and training initiatives. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Appraisal | |
653 | a Breast cancer | |
653 | a Clinical practice | |
653 | a Risk prediction model | |
653 | a Survey | |
653 | a Tool | |
700 | 1 | a Kop, Jean Lucu University of Lorraine4 aut |
700 | 1 | a Antoniou, Antonis C.u University of Cambridge4 aut |
700 | 1 | a Cunningham, Alex P.u University of Cambridge4 aut |
700 | 1 | a de Pauw, Antoineu Curie Institute, Paris4 aut |
700 | 1 | a Tischkowitz, Marcu University of Cambridge4 aut |
700 | 1 | a Ehrencrona, Hansu Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine,Skåne University Hospital4 aut0 (Swepub:lu)med-hen |
700 | 1 | a Dolbeault, Sylvieu University of Paris-Saclay,Curie Institute, Paris4 aut |
700 | 1 | a Robieux, Léonoreu Paris Descartes University4 aut |
700 | 1 | a Rhiem, Kerstinu University Hospital of Cologne4 aut |
700 | 1 | a Easton, Douglas F.u University of Cambridge4 aut |
700 | 1 | a Devilee, Peteru Leiden University Medical Centre4 aut |
700 | 1 | a Stoppa-Lyonnet, Dominiqueu Curie Institute, Paris4 aut |
700 | 1 | a Schmutlzer, Ritau University Hospital of Cologne4 aut |
710 | 2 | a Curie Institute, Parisb Paris Descartes University4 org |
773 | 0 | t Familial Cancerd : Springer Science and Business Media LLCg 17:1, s. 31-41q 17:1<31-41x 1389-9600x 1573-7292 |
856 | 4 | u http://dx.doi.org/10.1007/s10689-017-0014-xx freey FULLTEXT |
856 | 4 | u https://link.springer.com/content/pdf/10.1007%2Fs10689-017-0014-x.pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/00d5ad67-e55a-47ba-8a31-750866e6989b |
856 | 4 8 | u https://doi.org/10.1007/s10689-017-0014-x |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy